Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Raymond Townsend

Nephrology Philadelphia, PA Medical Doctor

NPI 1497786321 CMS profile 67175

3400 Civic Center Blvd, 1 South, Philadelphia, PA 19104

Open in the dashboard

General payments

$356,553

399 records reported · program years 2019–2025

Research payments

$56,755

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Raymond Townsend of Philadelphia, PA is reported in the CMS Open Payments database as having received $356,553 across 399 general payments and $56,755 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $106,090 89
2024 General $88,351 76
2023 General $67,174 115
2023 Research $33,268 4
2022 General $60,131 70
2021 General $17,582 11
2021 Research $5,950 1
2020 General $9,814 11
2020 Research $13,513 2
2019 General $7,412 27
2019 Research $4,025 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Raymond Townsend
  • Nephrology median
  • Middle half of Nephrology
  • National median

In program year 2025, general payments to Raymond Townsend were reported at $106,090. Among 8,186 Nephrology profiles paid that year, the median was $310 and the middle half received between $104 and $880.

Show as a table
Year Raymond Townsend Nephrology median Middle half National median
2019 $7,412 $236 $90–$588 $163
2020 $9,814 $135 $46–$364 $114
2021 $17,582 $202 $67–$551 $132
2022 $60,131 $242 $77–$695 $149
2023 $67,174 $254 $84–$766 $160
2024 $88,351 $300 $99–$852 $164
2025 $106,090 $310 $104–$880 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $169,688 232 payments
  2. AstraZeneca UK Limited $67,035 30 payments
  3. AstraZeneca Pharmaceuticals LP $27,997 21 payments
  4. Bard Peripheral Vascular, Inc. $26,950 13 payments
  5. Corcept Therapeutics $17,084 17 payments
  6. Janssen Pharmaceuticals, Inc $14,236 28 payments
  7. FUKUDA DENSHI Co., Ltd. $8,928 10 payments
  8. Medtronic Vascular, Inc. $8,047 27 payments
  9. Regeneron Pharmaceuticals, Inc. $5,820 5 payments
  10. Jazz Pharmaceuticals Inc. $5,129 9 payments
  11. Other $5,639 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $179,998 78 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $97,358 48 payments
  3. Travel and Lodging $60,339 148 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $7,750 3 payments
  5. Food and Beverage $6,109 117 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,000 1 payment
  7. Honoraria $1,500 2 payments
  8. Grant $1,500 2 payments
Products named General payments · program years 2019–2025
  1. SAPHNELO $60,000 25 payments
  2. SYMPLICITY G3 $45,271 65 payments
  3. Korlym $17,084 17 payments
  4. VS-2000 Vascular Screening $7,574 8 payments
  5. Tryvio $2,820 1 payment
  6. FARXIGA $1,960 1 payment
  7. IMFINZI $1,400 1 payment
  8. VS-2000 Vasucular Screening $750 1 payment
  9. VS-2000 Cardiovascular Screening $604 1 payment
  10. Kerendia $115 1 payment
  11. Other $260 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $39,218 5 payments
  2. Medtronic Vascular, Inc. $17,538 3 payments

Records

407 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nephrology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record